Lensar (LNSR) EBITDA Margin (2019 - 2026)

Lensar (LNSR) reported EBITDA Margin of 270.54% for Q1 2026, up 46369.0% year-over-year from N/an in Q1 2025, and up 3071.48% quarter-over-quarter from 9.1% in Q4 2025.

Lensar (LNSR) EBITDA Margin (2019 - 2026) Analysis & Trends

Lensar (LNSR) has 8 years of EBITDA Margin data on file, last reported at 270.54% in Q1 2026.

  • EBITDA Margin for Q1 2026 came in at 270.54%, up 46369.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 53.93% (up 16030.0% YoY), and the FY2025 annual result was 58.67%, up 965.0% from the prior year.
  • EBITDA Margin advanced to 270.54% in Q1 2026 per LNSR's latest filing, from 9.1% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 270.54% in Q1 2026 and troughed at 745.52% in Q1 2024.
  • A 5-year average of 79.16% and a median of 29.05% in 2025 frame the typical range for EBITDA Margin.
  • The sharpest annual moves came in 2024 and 2025: EBITDA Margin sank 69267 bps in 2024, then soared 55237 bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 25.54% in 2022, then slipped by 10 bps to 28.2% in 2023, then plunged by 348 bps to 126.24% in 2024, then jumped by 93 bps to 9.1% in 2025, then soared by 3071 bps to 270.54% in 2026.
  • Business Quant data shows LNSR's EBITDA Margin at 270.54% in Q1 2026, 9.1% in Q4 2025, and 29.05% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 12.05%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 15.55%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 16.24%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.04%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 19.94%
10 Lensar 70.05 Mn 70.34 Mn 6.38 Mn 270.54%

Historic Data

Download Data
DateValue
Mar 31, 2026 270.54%
Dec 31, 2025 -9.10%
Sep 30, 2025 -29.05%
Jun 30, 2025 -14.40%
Mar 31, 2025 -193.15%
Dec 31, 2024 -126.24%
Sep 30, 2024 -10.94%
Jun 30, 2024 -84.69%
Mar 31, 2024 -745.52%
Dec 31, 2023 -28.20%
Sep 30, 2023 -20.83%
Jun 30, 2023 -23.87%
Mar 31, 2023 -52.85%
Dec 31, 2022 -25.54%
Sep 30, 2022 -65.06%
Jun 30, 2022 -102.64%
Mar 31, 2022 -84.16%
Dec 31, 2021 -26.51%
Sep 30, 2021 -74.53%
Jun 30, 2021 -64.51%